All four parent studies are complete, and all patients have transitioned to a long-term follow-up study (LTF-303) SOMERVILLE, Mass.--(BUSINESS WIRE)--Updated data from bluebird bio inc.’s (NASDAQ: ...
A novel microfluidic device to model the human kidney The group targeting higher hemoglobin values experienced less decline in graft function. NEW ORLEANS—Kidney transplant recipients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback